When is radiotherapy used?

radiotherapy tolerance tests

SHORT VERSION

More than half of patients with cancer will receive radiation therapy during their care pathway.

Radiation therapy is a localized treat  that isrecommended for approximately 60% of patients with cancer.

Radiotherapy can be:

  • curative, when the aim is to cure the disease;

palliative, when the aim is to relieve a symptom, such as pain or bleeding.

Radiotherapy can be proposedalone or in combination with other treatments, particularly surgery and/or chemotherapy.. In this case, clinicians talk about concomitant radio-chemotherapy.. The sequence and duration of each treatment depend on the tumor type, location, stage, and on the patient’s general health status and age.

If performed before cancer surgery, radiation therapy is called neoadjuvant and its objectives are to:

  • reduce the tumor volume
  • facilitate surgery
  • reduce the risk of recurrence

If performed after surgery, radiation therapy is called adjuvant and its aims are to:

  • kill the remaining cancer cells that are not visible to the eye or on imaging
  • reduce the risk of recurrence

Radiotherapy is very frequently proposed to patients with:

  • gynecological cancers (breast, uterus, vagina)
  • urogenital cancers (bladder, prostate)
  • ENT cancers (pharynx, larynx, oral cavity)
  • digestive cancers (esophagus, stomach, colon, rectum)
  • lung cancer
  • brain cancer

The decision to prescribe radiotherapy is usually made during a multidisciplinary team meeting that brings together medical oncologists, radiation oncologists, surgeons, organ specialists, radiologists, nuclear medicine physicians, and pathologists.

When is radiotherapy used

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).